Literature DB >> 29325141

LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations.

Yongsheng Li1,2, Lili Li1, Zishan Wang1, Tao Pan1, Nidhi Sahni2, Xiyun Jin1, Guangjuan Wang1, Junyi Li1, Xiangyi Zheng1, Yunpeng Zhang1, Juan Xu1, Song Yi2, Xia Li1.   

Abstract

Gene regulatory network perturbations contribute to the development and progression of cancer, however, molecular determinants that mediate transcriptional perturbations remain a fundamental challenge for cancer biology. We show that transcriptional perturbations are widely mediated by long noncoding RNAs (lncRNAs) via integration of genome-wide transcriptional regulation with paired lncRNA and gene expression profiles. Systematic construction of an LncRNA Modulator Atlas in Pan-cancer (LncMAP) reveals distinct types of lncRNA regulatory molecules, which are expressed in multiple tissues, exhibit higher conservation. Strikingly, cancers with similar tissue origin share lncRNA modulators which perturb the regulation of cell cycle and immune response-related functions. Furthermore, we identified a large number of pan-cancer lncRNA modulators with potential clinical significance, which are differentially expressed in cancer or are strongly correlated with drug sensitivity across cell lines. Further stratification of cancer patients based on lncRNA-mediated transcriptional perturbations identifies subtypes with distinct survival rates. Finally, we made a user-friendly web interface available for exploring lncRNA-mediated transcriptional perturbations across cancer types. Our study provides a systems-level dissection of lncRNA-mediated regulatory perturbations in cancer, and also presents a valuable tool and resource for investigating the function of lncRNAs in cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29325141      PMCID: PMC5815097          DOI: 10.1093/nar/gkx1311

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  63 in total

Review 1.  LncRNA: a link between RNA and cancer.

Authors:  Guodong Yang; Xiaozhao Lu; Lijun Yuan
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

Review 3.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

4.  Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.

Authors:  Juan Xu; ZiShan Wang; Shengli Li; Juan Chen; Jinwen Zhang; Chunjie Jiang; Zheng Zhao; Jing Li; Yongsheng Li; Xia Li
Journal:  Brief Bioinform       Date:  2018-01-01       Impact factor: 11.622

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group.

Authors:  Thomas Beckers; Carmen Burkhardt; Heike Wieland; Petra Gimmnich; Thomas Ciossek; Thomas Maier; Karl Sanders
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

7.  Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.

Authors:  Qinghua Xu; Jinying Chen; Shujuan Ni; Cong Tan; Midie Xu; Lei Dong; Lin Yuan; Qifeng Wang; Xiang Du
Journal:  Mod Pathol       Date:  2016-03-18       Impact factor: 7.842

8.  Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature.

Authors:  Yolanda Sánchez; Victor Segura; Oskar Marín-Béjar; Alejandro Athie; Francesco P Marchese; Jovanna González; Luis Bujanda; Shuling Guo; Ander Matheu; Maite Huarte
Journal:  Nat Commun       Date:  2014-12-19       Impact factor: 14.919

9.  Functional analysis of transcription factor binding sites in human promoters.

Authors:  Troy W Whitfield; Jie Wang; Patrick J Collins; E Christopher Partridge; Shelley Force Aldred; Nathan D Trinklein; Richard M Myers; Zhiping Weng
Journal:  Genome Biol       Date:  2012-09-26       Impact factor: 13.583

10.  Systematic dissection of dysregulated transcription factor-miRNA feed-forward loops across tumor types.

Authors:  Wei Jiang; Ramkrishna Mitra; Chen-Ching Lin; Quan Wang; Feixiong Cheng; Zhongming Zhao
Journal:  Brief Bioinform       Date:  2015-12-09       Impact factor: 11.622

View more
  44 in total

Review 1.  Pathway perturbations in signaling networks: Linking genotype to phenotype.

Authors:  Yongsheng Li; Daniel J McGrail; Natasha Latysheva; Song Yi; M Madan Babu; Nidhi Sahni
Journal:  Semin Cell Dev Biol       Date:  2018-05-10       Impact factor: 7.727

2.  Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma.

Authors:  Jou-Ho Shih; Hsin-Yi Chen; Shin-Chih Lin; Yi-Chen Yeh; Roger Shen; Yaw-Dong Lang; Dung-Chi Wu; Chien-Yu Chen; Ruey-Hwa Chen; Teh-Ying Chou; Yuh-Shan Jou
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

3.  Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values.

Authors:  Mi Li; Wei-Ting Cheng; Hao Li; Zhi Zhang; Xiao-Li Lu; Si-Si Deng; Jian Li; Cai-Hong Yang
Journal:  Curr Med Sci       Date:  2021-10-20

4.  Illuminating lncRNA Function Through Target Prediction.

Authors:  Hua-Sheng Chiu; Sonal Somvanshi; Ting-Wen Chen; Pavel Sumazin
Journal:  Methods Mol Biol       Date:  2021

5.  Long noncoding RNA UCA1 promotes carboplatin resistance in retinoblastoma cells by acting as a ceRNA of miR-206.

Authors:  Nanye Wang; Huimin Fan; Shuhua Fu; Shaojun Li; Bin Zhou; Qifang Jin; Zhipeng You
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

6.  LncSEA: a platform for long non-coding RNA related sets and enrichment analysis.

Authors:  Jiaxin Chen; Jian Zhang; Yu Gao; Yanyu Li; Chenchen Feng; Chao Song; Ziyu Ning; Xinyuan Zhou; Jianmei Zhao; Minghong Feng; Yuexin Zhang; Ling Wei; Qi Pan; Yong Jiang; Fengcui Qian; Junwei Han; Yongsan Yang; Qiuyu Wang; Chunquan Li
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

7.  Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer.

Authors:  Xibo Zhao; Shanshan Cong; Qiuyan Guo; Yan Cheng; Tian Liang; Jing Wang; Guangmei Zhang
Journal:  Front Cell Dev Biol       Date:  2021-04-23

8.  Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Authors:  Zhou Su; Mi Chen; Ruilin Ding; Lian Shui; Qingmei Zhao; Wenjuan Luo
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

9.  lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1.

Authors:  Jing Luo; Huishan Wang; Li Wang; Gaoming Wang; Yu Yao; Kai Xie; Xiaokun Li; Lin Xu; Yi Shen; Binhui Ren
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

10.  Pan-cancer characterization of long non-coding RNA and DNA methylation mediated transcriptional dysregulation.

Authors:  Zhen Yang; Feng Xu; Haizhou Wang; Andrew E Teschendorff; Feng Xie; Yungang He
Journal:  EBioMedicine       Date:  2021-05-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.